Sandbox/00002: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | ||
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 100px; | | | | | | | | | | | | | B03 | | | | | | | | | | | | | |B03= | {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 100px; | | | | | | | | | | | | | B03 | | | | | | | | | | | | | |B03= | ||
<center>'''Ventilate—Infuse—Pump (VIP)'''</center> | <center>'''Ventilate—Infuse—Pump (VIP)'''<ref name="Weil-1969">{{Cite journal | last1 = Weil | first1 = MH. | last2 = Shubin | first2 = H. | title = The VIP approach to the bedside management of shock. | journal = JAMA | volume = 207 | issue = 2 | pages = 337-40 | month = Jan | year = 1969 | doi = | PMID = 5818156 }}</ref><ref name="Vincent-2013">{{Cite journal | last1 = Vincent | first1 = JL. | last2 = De Backer | first2 = D. | title = Circulatory shock. | journal = N Engl J Med | volume = 369 | issue = 18 | pages = 1726-34 | month = Oct | year = 2013 | doi = 10.1056/NEJMra1208943 | PMID = 24171518 }}</ref> | ||
</center> | |||
---- | ---- | ||
❑ Intubation with mechanical ventilation<br> | ❑ Intubation with mechanical ventilation<br> | ||
Line 32: | Line 34: | ||
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | ||
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 260px; | | | | | | | | | | | | | B05 | | | | | | | | | | | | | |B05= | {{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 260px; | | | | | | | | | | | | | B05 | | | | | | | | | | | | | |B05= | ||
<center>'''Immediate Goals'''</center> | <center>'''Immediate Goals'''<ref name="Dellinger-2013">{{Cite journal | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. | journal = Crit Care Med | volume = 41 | issue = 2 | pages = 580-637 | month = Feb | year = 2013 | doi = 10.1097/CCM.0b013e31827e83af | PMID = 23353941 }}</ref></center> | ||
---- | ---- | ||
❑ MAP >65–70 mmHg<br> | ❑ MAP >65–70 mmHg<br> | ||
Line 50: | Line 52: | ||
<sup>†</sup> For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock. | <sup>†</sup> For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 01:47, 8 April 2014
❑ Altered mental status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Intubation with mechanical ventilation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ CBC/DC/SMA-7/PT/PTT | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ MAP >65–70 mmHg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Classify and treat accodringly | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
† For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock.
References
- ↑ Weil, MH.; Shubin, H. (1969). "The VIP approach to the bedside management of shock". JAMA. 207 (2): 337–40. PMID 5818156. Unknown parameter
|month=
ignored (help) - ↑ Vincent, JL.; De Backer, D. (2013). "Circulatory shock". N Engl J Med. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518. Unknown parameter
|month=
ignored (help) - ↑ Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012". Crit Care Med. 41 (2): 580–637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941. Unknown parameter
|month=
ignored (help)